Valuation: OPC Pharmaceutical

Market Cap 1,57000Cr 5.96Cr 5.24Cr 4.87Cr 4.47Cr 8.4Cr 574.24Cr 8.53Cr 58Cr 23Cr 282.31Cr 22Cr 22Cr 976.11Cr P/E 2024
17.6x
P/E 2025 15.6x
Enterprise Value 1,25100Cr 4.75Cr 4.17Cr 3.88Cr 3.56Cr 6.69Cr 457.5Cr 6.79Cr 46Cr 18Cr 224.92Cr 18Cr 17Cr 777.67Cr EV / Sales 2024
1.4x
EV / Sales 2025 1.08x
Free-Float
57.32%
Yield 2024 *
-
Yield 2025 3.33%
20/07 Opc Pharmaceutical Joint Stock Company Receives Tax Authority Fine of VND 22,000,000 for Late Submission of Natural Resource Tax Returns CI
07/07 OPC Pharmaceutical Joint Stock Company Announces Committee Changes, Effective July 2, 2026 CI
26/06 OPC Pharmaceutical Joint Stock Company Receives Approval for the Termination of Operations of Nghe an Branch CI
29/04 Opc Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 25, 2026 CI
28/04 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
06/04 OPC Pharmaceutical Joint Stock Company announces Annual dividend, payable on July 20, 2026 CI
30/01 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
26/25/26 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
24/25/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/25/28 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/25/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
23/24/23 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
30/24/30 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 day-2.56%
1 week+4.75%
Current month+3.42%
1 month+0.05%
3 months+9.43%
6 months+10.66%
Current year+2.13%
1 week 19,500
Extreme 19500
21,500
1 month 18,250
Extreme 18250
21,500
Current year 18,250
Extreme 18250
21,500
1 year 18,034.19
Extreme 18034.188
21,500
3 years 17,948.72
Extreme 17948.7179
23,076.92
5 years 17,948.72
Extreme 17948.7179
26,239.32
10 years 12,767.32
Extreme 12767.3157
26,239.32
Manager TitleAgeSince
Chief Executive Officer 60 14/07/2021
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer 56 02/05/2011
Director TitleAgeSince
Chairman 70 01/04/2011
Chairman - 22/10/2021
Director/Board Member 50 22/10/2021
Date Insider Type Main position Quantity % Market Cap.
05/08/24 Sell

Controller/Auditor

2,00,000 0.3123%
07/03/24 Buy 85,84,829 13.4031%
18/12/23 Sell 1,11,34,200 17.3834%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%+4.75%+4.08%+5.43% 6.12Cr
+0.86%+1.43%+48.50%+160.39% 1,05700Cr
+1.59%+4.09%+55.34%+53.96% 62TCr
+0.95%+1.91%+35.91%+81.14% 45TCr
+1.60%+6.25%+33.95%+29.84% 34TCr
-0.60%+1.52%+35.68%+39.76% 30TCr
-0.14%+0.60%+16.17%+17.53% 26TCr
+0.09%-2.82%-28.29%-41.71% 22TCr
+1.22%+2.66%+21.87%+59.73% 20TCr
-1.18%-3.70%+14.23%+66.51% 16TCr
Average +0.08%+0.99%+23.75%+47.26% 36.14TCr
Weighted average by Cap. +0.54%+1.92%+35.73%+77.61%

Financials

2024 2025
Net sales 97TCr 3.68Cr 3.23Cr 3Cr 2.76Cr 5.18Cr 354.27Cr 5.26Cr 36Cr 14Cr 174.17Cr 14Cr 14Cr 602.2Cr 1,12300Cr 4.27Cr 3.75Cr 3.48Cr 3.2Cr 6.01Cr 410.74Cr 6.1Cr 41Cr 16Cr 201.94Cr 16Cr 16Cr 698.2Cr
Net income 11TCr 40.66L 35.71L 33.21L 30.48L 57.26L 39Cr 58.15L 3.94Cr 1.54Cr 19Cr 1.53Cr 1.49Cr 67Cr 12TCr 44.01L 38.66L 35.95L 32.99L 61.98L 42Cr 62.94L 4.27Cr 1.67Cr 21Cr 1.65Cr 1.62Cr 72Cr
Net Debt -25TCr -93.92L -82.49L -76.72L -70.4L -1.32Cr -90Cr -1.34Cr -9.11Cr -3.56Cr -44Cr -3.53Cr -3.45Cr -153.75Cr -32TCr -1.21Cr -1.06Cr -99.02L -90.86L -1.71Cr -116.74Cr -1.73Cr -12Cr -4.59Cr -57Cr -4.55Cr -4.45Cr -198.44Cr
Logo OPC Pharmaceutical
OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.
Employees
871
Date Price Change Volume
24/26/24 ₫20,950.00 -2.56% 4,039
23/26/23 ₫21,500.00 +2.38% 3,819
22/26/22 ₫21,000.00 0.00% 23,996
21/26/21 ₫21,000.00 -1.18% 20,21,201
20/26/20 ₫21,250.00 +6.25% 1,000